These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
164 related articles for article (PubMed ID: 24097424)
1. Lipid-lowering drugs associated with slower motor decline in the elderly adults. Dumurgier J; Singh-Manoux A; Tavernier B; Tzourio C; Elbaz A J Gerontol A Biol Sci Med Sci; 2014 Feb; 69(2):199-206. PubMed ID: 24097424 [TBL] [Abstract][Full Text] [Related]
2. Decline in Fast Gait Speed as a Predictor of Disability in Older Adults. Artaud F; Singh-Manoux A; Dugravot A; Tzourio C; Elbaz A J Am Geriatr Soc; 2015 Jun; 63(6):1129-36. PubMed ID: 26096387 [TBL] [Abstract][Full Text] [Related]
8. Statins as a free pass: Body mass index and other cardiovascular risk factors among lipid-lowering medication users and nonusers in the California Men's Health Study. Sidell MA; Ghai NR; Reynolds K; Jacobsen SJ; Scott R; Van Den Eeden S; Caan B; Quinn VP Prev Med; 2019 Dec; 129():105822. PubMed ID: 31470024 [TBL] [Abstract][Full Text] [Related]
9. Safety and efficacy of statin treatment alone and in combination with fibrates in patients with dyslipidemia: a meta-analysis. Choi HD; Shin WG Curr Med Res Opin; 2014 Jan; 30(1):1-10. PubMed ID: 24063624 [TBL] [Abstract][Full Text] [Related]
10. Lipid parameters, lipid lowering drugs and the risk of venous thromboembolism. Delluc A; Malécot JM; Kerspern H; Nowak E; Carre JL; Mottier D; Le Gal G; Lacut K Atherosclerosis; 2012 Jan; 220(1):184-8. PubMed ID: 22035572 [TBL] [Abstract][Full Text] [Related]
11. Primary prevention with lipid lowering drugs and long term risk of vascular events in older people: population based cohort study. Alpérovitch A; Kurth T; Bertrand M; Ancelin ML; Helmer C; Debette S; Tzourio C BMJ; 2015 May; 350():h2335. PubMed ID: 25989805 [TBL] [Abstract][Full Text] [Related]
12. Editorial: Statins or Fibrates for the Primary Prevention of Stroke in the Elderly. Faith Makes Some Things Achievable, But Not AII. Athyros VG; Tziomalos K; Karagiannis A Curr Vasc Pharmacol; 2015; 13(6):696-8. PubMed ID: 26459809 [No Abstract] [Full Text] [Related]
13. Fibrates and niacin: is there a place for them in clinical practice? Wierzbicki AS; Viljoen A Expert Opin Pharmacother; 2014 Dec; 15(18):2673-80. PubMed ID: 25318657 [TBL] [Abstract][Full Text] [Related]
14. Motor function in the elderly: evidence for the reserve hypothesis. Elbaz A; Vicente-Vytopilova P; Tavernier B; Sabia S; Dumurgier J; Mazoyer B; Singh-Manoux A; Tzourio C Neurology; 2013 Jul; 81(5):417-26. PubMed ID: 23803317 [TBL] [Abstract][Full Text] [Related]
15. Who receives lipid-lowering drugs: the effects of comorbidities and patient characteristics on treatment initiation. Yang CC; Jick SS; Testa MA Br J Clin Pharmacol; 2003 Mar; 55(3):288-98. PubMed ID: 12630980 [TBL] [Abstract][Full Text] [Related]
16. Use of Fibrates Monotherapy in People with Diabetes and High Cardiovascular Risk in Primary Care: A French Nationwide Cohort Study Based on National Administrative Databases. Roussel R; Chaignot C; Weill A; Travert F; Hansel B; Marre M; Ricordeau P; Alla F; Allemand H PLoS One; 2015; 10(9):e0137733. PubMed ID: 26398765 [TBL] [Abstract][Full Text] [Related]